Wockhardt-made drug in U.S. FDA recall action

U.S.-based distributor PD-Rx Pharmaceuticals has been asked to recall more than 60,000 bottles of bacterial infection treatment azithromycin tablets made by Mumbai-based Indian drugmaker Wockhardt, the Economic Times reports. The recall of 62,555 bottles was made as a follow-up to a Wockhardt voluntary recall made in April 29 of last year, the Economic Times said, citing a U.S. Food and Drug Administration Enforcement Report. In June 2015, Wockhardt was hauled up for its third voluntary recall in as many months. The company has faced FDA bans on drugs manufactured at its two facilities in Aurangabad, India--one in Chikalthana and the other in Waluj. Report